Related Experiment Video

Updated: May 21, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Immunization of newborns with bacterial conjugate vaccines

Anita H J van den Biggelaar1, William S Pomat

  • 1Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, PO Box 855, West Perth, WA 6872, Australia. Anita.vandenBiggelaar@Crucell.com

Vaccine
|June 26, 2012
PubMed

Insights

Neonatal bacterial conjugate vaccines, like those for Haemophilus influenzae type b and pneumococcus, are safe for newborns. However, evidence for earlier clinical protection from these infant vaccination schedules is still needed.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Bacterial conjugate vaccines link polysaccharides to carrier proteins, enhancing T-cell memory responses.
  • Successful conjugate vaccines for Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis protect children from invasive diseases.

Purpose of the Study:

  • This review discusses the application and efficacy of conjugate vaccines in human newborns.
  • To evaluate the safety and potential benefits of early-life conjugate vaccination.

Main Methods:

  • Review of existing clinical trials and studies on neonatal conjugate vaccination schedules.
  • Analysis of data regarding immune tolerance induction and clinical protection timelines.

Main Results:

  • Neonatal vaccination schedules for Haemophilus influenzae type b and pneumococcal conjugate vaccines have been trialed and found to be safe.
  • Most studies show no induction of immune tolerance in newborns receiving these vaccines.

Conclusions:

  • While neonatal conjugate vaccination is safe, its ability to provide earlier clinical protection in the first few months of life requires further demonstration.
  • Further research is needed to confirm the timing of clinical protection induced by neonatal conjugate vaccine administration.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Mechanism of Conjugation01:19

Mechanism of Conjugation

Bacterial conjugation is a mechanism of horizontal gene transfer that enables the exchange of genetic material between bacterial cells through direct contact. This process is facilitated by a donor cell carrying a conjugative plasmid, which encodes genes necessary for pilus formation, DNA replication, and transfer. The conjugative plasmid plays a central role in initiating and executing the transfer of genetic material.The tra region of the conjugative plasmid encodes proteins responsible for...
Vaccinations01:51

Vaccinations

Overview
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.